{"entity":{"type":"insider","cik":"0001738054","url":"/insider/0001738054","json_url":"/insider/0001738054.json","name":"Patel Gautam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2020-03-10","last":"2025-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Patel Gautam","source":"filing","n_filings":10,"first_seen":"2020-03-10","last_seen":"2025-06-18"}],"transactions":[{"id":4929266,"accession":"0001628280-25-032108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-032108","line_url":"/filing/0001628280-25-032108#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94906.0,"shares_display":"94,906","price_per_share":8.02,"price_display":"8.02","price_state":"stated","total_value":761146.12,"total_display":"761,146.12","total_whole":"761,146","shares_owned_after":1609144.0,"shares_owned_after_display":"1,609,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":4503943,"accession":"0001628280-25-030958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-030958","line_url":"/filing/0001628280-25-030958#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56426.0,"shares_display":"56,426","price_per_share":8.02,"price_display":"8.02","price_state":"stated","total_value":452536.52,"total_display":"452,536.52","total_whole":"452,537","shares_owned_after":1704050.0,"shares_owned_after_display":"1,704,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-12","scope":"insider"},{"id":4888486,"accession":"0001628280-25-022719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-022719","line_url":"/filing/0001628280-25-022719#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4900.0,"shares_display":"4,900","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":39200.0,"total_display":"39,200.00","total_whole":"39,200","shares_owned_after":1720218.0,"shares_owned_after_display":"1,720,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-05","filed_date":"2025-05-06","scope":"insider"},{"id":4888482,"accession":"0001628280-25-022719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-022719","line_url":"/filing/0001628280-25-022719#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3768.0,"shares_display":"3,768","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":30144.0,"total_display":"30,144.00","total_whole":"30,144","shares_owned_after":1725118.0,"shares_owned_after_display":"1,725,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-06","scope":"insider"},{"id":4274837,"accession":"0001628280-25-016184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-016184","line_url":"/filing/0001628280-25-016184#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":664000.0,"total_display":"664,000.00","total_whole":"664,000","shares_owned_after":1728886.0,"shares_owned_after_display":"1,728,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-02","scope":"insider"},{"id":4994462,"accession":"0001628280-25-010679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-010679","line_url":"/filing/0001628280-25-010679#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":712000.0,"total_display":"712,000.00","total_whole":"712,000","shares_owned_after":1808886.0,"shares_owned_after_display":"1,808,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":4772261,"accession":"0001628280-25-004064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-004064","line_url":"/filing/0001628280-25-004064#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":8.14,"price_display":"8.14","price_state":"stated","total_value":651200.0,"total_display":"651,200.00","total_whole":"651,200","shares_owned_after":1888886.0,"shares_owned_after_display":"1,888,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":5172780,"accession":"0001628280-25-001153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-001153","line_url":"/filing/0001628280-25-001153#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62590.0,"shares_display":"62,590","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":501345.9,"total_display":"501,345.90","total_whole":"501,346","shares_owned_after":1968886.0,"shares_owned_after_display":"1,968,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":4070564,"accession":"0001628280-25-000581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-000581","line_url":"/filing/0001628280-25-000581#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17410.0,"shares_display":"17,410","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":139454.1,"total_display":"139,454.10","total_whole":"139,454","shares_owned_after":2031476.0,"shares_owned_after_display":"2,031,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":5262233,"accession":"0001209191-21-070646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-070646","line_url":"/filing/0001209191-21-070646#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":210500.0,"total_display":"210,500.00","total_whole":"210,500","shares_owned_after":258784.0,"shares_owned_after_display":"258,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-20","scope":"insider"},{"id":2894529,"accession":"0000899243-20-007820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-007820","line_url":"/filing/0000899243-20-007820#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117889.0,"shares_display":"117,889","price_per_share":3.94,"price_display":"3.94","price_state":"stated","total_value":464482.66,"total_display":"464,482.66","total_whole":"464,483","shares_owned_after":156107.0,"shares_owned_after_display":"156,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-10","scope":"insider"},{"id":2894520,"accession":"0000899243-20-007820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-007820","line_url":"/filing/0000899243-20-007820#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738054","owner_name":"Patel Gautam","owner_display_name":"Patel Gautam","owner_url":"/insider/0001738054","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32111.0,"shares_display":"32,111","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":124590.68,"total_display":"124,590.68","total_whole":"124,591","shares_owned_after":38218.0,"shares_owned_after_display":"38,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001723128","name":"Amneal Pharmaceuticals, Inc.","url":"/issuer/0001723128","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2020-03-10","last_seen":"2025-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001738054","retrieved_at":"2026-08-24T05:30:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}